Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$567K Sell
60,765
-7,200
-11% -$66.9K 0.01% 565
2026
Q1
$680K Buy
67,965
+5,793
+9% +$60.3K 0.01% 497
2025
Q4
$629K Sell
62,172
-2,941
-5% -$28K 0.01% 502
2025
Q3
$584K Buy
65,113
+1,642
+3% +$15.8K 0.01% 526
2025
Q2
$658K Buy
63,471
+1,540
+2% +$16.2K 0.01% 479
2025
Q1
$637K Buy
61,931
+14,412
+30% +$142K 0.01% 481
2024
Q4
$453K Buy
47,519
+5,565
+13% +$54.5K 0.01% 491
2024
Q3
$444K Buy
41,954
+476
+1% +$4.6K 0.01% 488
2024
Q2
$343K Sell
41,478
-569
-1% -$4.76K 0.01% 520
2024
Q1
$357K Buy
42,047
+7,912
+23% +$66.1K 0.01% 526
2023
Q4
$281K Buy
34,135
+2,655
+8% +$21.9K ﹤0.01% 555
2023
Q3
$262K Sell
31,480
-371
-1% -$3.09K ﹤0.01% 552
2023
Q2
$267K Buy
31,851
+4,894
+18% +$41.8K ﹤0.01% 558
2023
Q1
$219K Buy
26,957
+3,993
+17% +$31.8K ﹤0.01% 584
2022
Q4
$184K Buy
22,964
+7,758
+51% +$52.8K ﹤0.01% 605
2022
Q3
$93K Buy
+15,206
New +$98.4K ﹤0.01% 597

Other funds holding HLN

Fiduciary Trust's HLN Position: Q2 2026 in Review

Fiduciary Trust reduced its Haleon (HLN) stake by 11% in Q2 2026, selling an estimated $66.9K and leaving 60,765 shares worth $567K. The position accounts for 0.01% of the portfolio, ranked #565.

Fiduciary Trust first reported a position in HLN in Q3 2022 and has held it in 16 quarters since. The position peaked at $680K in Q1 2026. 641 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • Fiduciary Trust held 60,765 shares of Haleon worth $567K as of Q2 2026.
  • Fiduciary Trust sold 7,200 Haleon shares in Q2 2026, an estimated $66.9K.
  • Haleon made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #565 holding.
  • Fiduciary Trust first reported a position in Haleon in Q3 2022 and has held it in 16 quarters since.
  • Fiduciary Trust's Haleon position peaked at $680K in Q1 2026.
  • 641 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.